/GN.CO
GN.CO Stock - GN Store Nord A/S
Healthcare|Medical - DevicesCPH
$104.25+1.56%
+$1.60 (+1.56%) • Dec 23
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.49
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $114.68
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GN.CO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$103.21 – $105.29
TARGET (TP)$119.89
STOP LOSS$95.91
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.79
52W High$157.00
52W Low$79.32
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $17.98B | $18.12B | $18.69B | $15.78B | $13.45B |
| Gross Profit | $9.56B | $9.04B | $9.13B | $8.68B | $7.30B |
| Gross Margin | 53.2% | 49.9% | 48.9% | 55.0% | 54.3% |
| Operating Income | $1.86B | $869.00M | $1.11B | $2.40B | $1.63B |
| Net Income | $988.00M | $228.00M | $511.00M | $1.76B | $1.25B |
| Net Margin | 5.5% | 1.3% | 2.7% | 11.1% | 9.3% |
| EPS | $6.79 | $1.64 | $4.00 | $13.63 | $9.72 |
Company Overview
GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer technology solutions in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GN.COBeat Rate
28%
Last 18 quarters
Avg Surprise
-23.8%
EPS vs Estimate
Beats / Misses
5/13
Last 12 quarters
Latest EPS
$0.50
Q4 2025
EPS Surprise History
Q1 24
-87.7%
$0.24vs$1.95
Q2 24
+91.2%
$1.74vs$0.91
Q3 24
-56.3%
$0.66vs$1.51
Q4 24
+6.3%
$1.86vs$1.75
Q1 25
+4.1%
$2.52vs$2.42
Q2 25
-71.5%
$0.49vs$1.72
Q3 25
-25.2%
$1.13vs$1.51
Q4 25
-83.6%
$0.50vs$3.05
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | $2.74 | — | — | — |
Q4 2025 | Nov 5, 2025 | $3.05 | $0.50 | -83.6% | ✗ MISS |
Q3 2025 | Aug 21, 2025 | $1.51 | $1.13 | -25.2% | ✗ MISS |
Q2 2025 | Apr 30, 2025 | $1.72 | $0.49 | -71.5% | ✗ MISS |
Q1 2025 | Feb 6, 2025 | $2.42 | $2.52 | +4.1% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $1.75 | $1.86 | +6.3% | ✓ BEAT |
Q3 2024 | Aug 22, 2024 | $1.51 | $0.66 | -56.3% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.91 | $1.74 | +91.2% | ✓ BEAT |
Q1 2024 | Feb 8, 2024 | $1.95 | $0.24 | -87.7% | ✗ MISS |
Q4 2023 | Nov 10, 2023 | $1.05 | $1.46 | +39.0% | ✓ BEAT |
Q3 2023 | Aug 17, 2023 | $0.99 | $0.23 | -76.8% | ✗ MISS |
Q2 2023 | Apr 27, 2023 | $-0.22 | $-0.42 | -90.9% | ✗ MISS |
Q1 2023 | Feb 9, 2023 | $2.62 | $2.05 | -21.8% | ✗ MISS |
Q4 2022 | Nov 11, 2022 | $2.03 | $1.54 | -24.1% | ✗ MISS |
Q3 2022 | Aug 18, 2022 | $2.00 | $1.89 | -5.5% | ✗ MISS |
Q2 2022 | May 5, 2022 | $-1.29 | $-1.49 | -15.5% | ✗ MISS |
Q1 2022 | Feb 10, 2022 | $3.33 | $3.29 | -1.2% | ✗ MISS |
Q4 2021 | Oct 29, 2021 | $3.31 | $3.33 | +0.6% | ✓ BEAT |
Q3 2021 | Aug 19, 2021 | $3.61 | $3.25 | -10.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about GN.CO
What is GN.CO's current stock price?
GN Store Nord A/S (GN.CO) is currently trading at $104.25 per share. The stock has moved +1.56% today.
What is the analyst price target for GN.CO?
No analyst price targets are currently available for this stock.
What sector is GN Store Nord A/S in?
GN Store Nord A/S operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the CPH exchange.
What is GN.CO's market cap?
GN Store Nord A/S has a market capitalization of $15.18 billion, making it a large-cap company.
Does GN.CO pay dividends?
No, GN Store Nord A/S does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMBU-B.CO
Ambu A/S
$87.75
Mkt Cap: $23.4B
BAVA.CO
Bavarian Nordic A/S
$189.45
Mkt Cap: $14.8B
BIOPOR.CO
BioPorto A/S
$1.04
Mkt Cap: $0.5B
BRAINP.CO
Brain+ A/S
$0.01
Mkt Cap: $0.0B
CHEMM.CO
ChemoMetec A/S
$683.50
Mkt Cap: $11.9B
DEMANT.CO
Demant A/S
$214.00
Mkt Cap: $45.3B
GUBRA.CO
Gubra A/S
$517.00
Mkt Cap: $8.4B
MONSO.CO
Monsenso A/S
$0.16
Mkt Cap: $0.0B
SMSMED.CO
Scandinavian Medical Solutions A/S
$4.75
Mkt Cap: $0.1B
VIRO.CO
ViroGates A/S
$12.05
Mkt Cap: $0.1B
Explore stocks similar to GN.CO for comparison